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ABSTRACT  
The aim of this study was to understand the role of HIF1alpha during bovine cumulus cell 
complexes (COCs) maturation by investigating the expression of related genes in cumulus 
cells. For this purpose, COCs were isolated from ovaries collected at a local abattoir and were 
divided into the groups of immature (control), in vitro matured (IVM/control), and matured 
with echinomycin which is an inhibitor of HIF1alpha activity (IVM/E). As expected, cumulus 
cells expanded during IVM in the control group, which was markedly inhibited in the 
echinomycin treated group. Several genes (n=13) were assessed for the transcript levels in 
cumulus cells. Among them, HAS2, TNFAIP6, TMSB4, TMSB10, GATM, GLUT1, CX43, 
COX2, PTGES, and STAR had decreased expression in the IVM/E group (p<0.05). 
Moreover, protein levels of STAR, HAS2, and PCNA were decreased (p<0.05), but not of 
activated Caspase 3 that remained unaffected. At the same time, progesterone output was 
found to be decreased in the IVM/E group. Another HIF1alpha blocker, PX-478, showed 
identical results. Inhibition of HIF1alpha due to echinomycin and PX-478 also resulted in a 
significant decrease in oocyte maturation and blastocyst rates (p<0.05). These results lead to 
the conclusion that HIF1alpha is one of the important factors that control intercellular 
communication within COCs, maturation rates of oocytes, blastocyst rates, and steroidogenic 
activity. 
Key words: HIF1alpha, bovine cumulus cells, in vitro maturation. 
 







Ziel dieser Studie war es, die Rolle von HIF1alpha während der Reifung von Rinder-
Kumuluszellkomplexen (COCs) zu untersuchen, indem die Expression von relevanten Genen 
in Kumuluszellen bestimmt wurde. Dazu wurden COCs aus Ovarien von Schlachtrindern 
isoliert und in die Gruppen unterteilt: unreif (Kontrolle), in vitro gereift (IVM/Kontrolle) und 
gereift mit Echinomycin (E), einem Inhibitor der HIF1alpha-Aktivität (IVM/E). Wie erwartet, 
waren in der Kontrollgruppe die Kumuluszellen im Anschluss an die IVM expandiert, 
während dies in der mit E behandelten Gruppe deutlich gehemmt war. Mehrere Gene (n=13) 
wurden auf der Transkriptebene in den Kumuluszellen untersucht. Unter ihnen hatten HAS2, 
TNFAIP6, TMSB4, TMSB10, GATM, GLUT1, CX43, COX2, PTGES und STAR eine 
verminderte Expression in der IVM/E-Gruppe (p<0.05). Ausserdem waren die 
Proteinkonzentrationen von STAR, HAS2 und PCNA vermindert (p<0.05), nicht jedoch von 
der aktivierten Caspase 3, die unbeeinflusst blieb. Gleichzeitig war die Progesteronproduktion 
in der IVM/E-Gruppe vermindert. Ein weiterer HIF1alpha-Blocker, PX-478, zeigte identische 
Ergebnisse. Die Hemmung von HIF1alpha durch E und PX-478 führte ebenfalls zu einer 
signifikanten Abnahme der Eizellreifung und der Blastozystenrate (p<0.05). Dies lässt den 
Schluss zu, dass HIF1alpha einer der wichtigen Faktoren ist, der die interzelluläre 
Kommunikation innerhalb der COCs, die Maturation der Oozyten, die Blastozystenraten und 
die steroidogene Aktivität kontrollieren. 
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Abstract
Various metabolic and hormonal factors expressed in cumulus cells are positively correlated
with the in vitro maturation (IVM) of oocytes. However, the role of hypoxia sensing both during
maturation of cumulus–oocyte complexes (COCs) as well as during the resumption of meiosis
remains uncertain. HIF1alpha plays major roles in cellular responses to hypoxia, and here we
investigated its role during bovine COCmaturation by assessing the expression of related genes in
cumulus cells. COCs were divided into the following groups: immature (control), in vitro matured
(IVM/control), or matured in the presence of a blocker of HIF1alpha activity (echinomycin, IVM/E).
We found an inhibition of cumulus cell expansion in IVM/E, compared with the IVM/control.
Transcript levels of several factors (n = 13) were assessed in cumulus cells. Decreased expression
of HAS2, TNFAIP6, TMSB4, TMSB10, GATM, GLUT1, CX43, COX2, PTGES, and STAR was found
in IVM/E (P < 0.05). Additionally, decreased protein levels were detected for STAR, HAS2, and
PCNA (P < 0.05), while activated-Caspase 3 remained unaffected in IVM/E. Progesterone output
decreased in IVM/E. The application of PX-478, another blocker of HIF1alpha expression, yielded
identical results. Negative effects of HIF1alpha suppression were further observed in the signifi-
cantly decreased oocyte maturation and blastocyst rates from COCs matured with echinomycin
(P < 0.05) or PX-478 (P < 0.05). These results support the importance of HIF1alpha for COC mat-
uration and subsequent embryo development. HIF1alpha is a multidirectional factor controlling
intercellular communication within COCs, steroidogenic activity, and oocyte development rates,
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Summary sentence
HIF1alpha is functionally involved in controlling in vitro embryo production output in cattle.
Suppression of its expression and/or function in cumulus cells during in vitro maturation impacts
intercellular communication, steroid production and, consequently, oocyte and blastocyst rates.
Key words: HIF1alpha, bovine cumulus cells, in vitro maturation.
Introduction
In most mammalian species, in vivo maturation of the oocyte
takes place in response to the preovulatory LH surge and involves
its nuclear and cytoplasmic remodeling associated with the
developmental transition from the primary to secondary oocyte (see
reviewed in: [1]). Concomitantly, the secondary oocyte acquires
its fertilization competence and becomes capable of promoting
embryonic development [2]. The nuclear events are manifested by
germinal-vesicle breakdown, i.e., resumption of meiotic division,
resulting in the extrusion of the first polar body into the perivitelline
space.
The oocyte is surrounded by layers of tightly packed follicular
epithelial cells, constituting the cumulus–oocyte complex (COC),
that are important in the acquisition of oocyte developmental com-
petence [3–5]. They control nuclear and cytoplasmic maturation of
the oocyte, keep the oocyte under meiotic arrest, and participate
in the induction of meiotic resumption [3, 6–8]. Prior to ovula-
tion in vivo, as well as during meiotic resumption in vitro, these
compact cumulus granulosa cells disperse into a three-dimensional
structure rich in extracellular matrix characterized by the synthesis
of increased amounts of hyaluronic acid (HA) [9]. This process
of cumulus expansion is associated with concomitant fundamen-
tal developmental changes of the oocyte, significantly affecting its
maturation [10]. Besides being a structural molecule, HA is also an
important signaling molecule and its production correlates positively
with the resumption of oocyte meiotic competence [11, 12]. Several
other molecules contribute to the formation of the matrix and/or
are involved in the stabilization of HA, including the tumor necrosis
factor alpha-induced protein 6 (TNFAIP6) [13]. Together with some
other factors, both HA and TNFAIP6 act as indirect quality evalua-
tion markers and indicators of oocyte maturation [14].
Due to the lack of vasculature within growing follicles, the
communication between the oocyte and cumulus cells during oocyte
maturation is guaranteed by gap junctions [15–17]. Functioning
as the main intercellular link, gap junctions facilitate the transfer
of small molecules including second messengers and ions [18].
The functionality of some gap junctions’ components, e.g., CX43,
was proved indispensable for cumulus expansion and, thus, for
oocyte maturation [19]. Cumulus cells excrete the steroid hormones,
estrogens and progesterone (P4) [20, 21]. Besides being involved
in controlling follicular growth, estradiol (E2) promotes the devel-
opment of cumulus cells and the synthesis of HA as well as some
of the gap junction proteins, including CX43 [22, 23]. Similarly,
P4 secreted from cumulus cells is involved in the acquisition of
oocyte meiotic competence and nuclear competence [24, 25]. This
demonstrates that the oocyte and cumulus cells work as a functional
entity and the presence of expanded cumulus cells is a conditio
sine qua non for the oocyte to acquire fertilization competence.
Following this line, arachidonic acid metabolites, like prostaglandins
(PGs), are involved in the functional interplay between the cumulus
and oocyte, due to their versatile mitogenic, differentiation, and
immunomodulatory properties [21]. Other cumulus-derived factors
used as specific markers of oocyte maturation include thymosin
beta-4 and -10 (TMSB4 and TMSB10) [26, 27], small proteins (4–
10 kDa) involved in several cellular processes like cell motility and
differentiation or anti-inflammatory processes [28].
Oxygen (O2) is an essential component of the environment
during oocyte maturation, both in vivo and in vitro. This also applies
to the bovine species, in which varying O2 saturation conditions
applied in vitro have been shown to affect oocyte maturation and
developmental competence, as well as blastocyst rates and embryonic
gene expression [29–32]. The actual O2 content of ovarian follicles is
difficult to determine and the response to hypoxic conditions in vitro
may depend on culture conditions, e.g., on energy substrate content
[33], and may, thus, not fully reflect the situation in vivo. This can
also lead to apparently contradictory conclusions, with reduced O2
tension being reported to exert either no, negative, or positive effects
on in vitro maturation (IVM) of oocytes in different species [30, 31,
34–36], while supporting improved developmental competence of
embryos, with higher blastocyst rates being observed. Thus, clearly,
isolated COCs and developing blastocysts adapt to different in vitro
experimental conditions.
The cellular effects of hypoxia are known to be mediated mainly
through hypoxia-inducible factors (HIFs), with HIF1alpha (encoded
byHIF1A gene) being the most known and thoroughly investigated.
Responding to changing O2 concentrations, HIF1alpha acts as a
transcription factor in heterodimer complexes with its constitutively
expressed binding partner, HIF1beta [37–39]. Its expression in gran-
ulosa cells is FSH- and hCG-dependent [40]. Interestingly, the expres-
sion of both HIF1alpha and HIF1beta also appears to be dependent
on the nuclear progesterone receptor (PGR), as shown in murine
ovaries [41]. Thus, in PGR knockout mice an anovulatory phenotype
was observed associated with reduced expression of HIF1alpha. Fur-
thermore, blocking HIF1 complex activity by applying echinomycin,
a specific inhibitor of HIF1alpha DNA binding capability, prevented
ovulation and affected expression of PGR-dependent genes, estab-
lishing a causality between PGR and HIF1alpha functionality in reg-
ulating ovulation [41]. Moreover, HIF1alpha is a direct and potent
regulator of STAR-mediated steroidogenesis in granulosa cells, as
knocking down and/or blocking its functionality by echinomycin
suppressed both basal and cAMP-induced STAR expression, under
both normoxic (20% O2) and reduced oxygen tension conditions
[42]. Most recently, the involvement of HIF1alpha in regulating
aromatase (CYP19A1) expression in granulosa cells of cattle was
shown [43].
Cumulatively, HIF1 complex is an important factor multidirec-
tionally affecting cellular functions in virtually all body systems,
including the reproductive organs (see reviewed in: [44]). Accord-
ingly, here, considering the importance of O2 sensing in regulating
ovarian function,we aimed to explore the involvement of HIF1alpha
during IVM of COCs in a bovine model, by blocking HIF1alpha







































































Role of HIF1alpha in regulating IVP output in cattle, 2021, Vol. 104, No. 2 481
Figure 1. Experimental design of the study.
hypothesis that HIF1alpha mediates the expression of cumulus-
derived markers of oocyte maturation and affects the development
rates of embryos obtained from COCs in which HIF1alpha was
blocked. Additionally, the steroidogenic output from cumulus cells,
as well as apoptotic and proliferative effects were determined.
Materials and methods
Cumulus–oocyte complex isolation
Ovaries used in the present study were obtained at a local slaugh-
terhouse complying with national animal welfare and meat quality
guidelines. Only samples from healthy animals were used. After
collection, ovaries were transported to the laboratory in a 0.9%
NaCl solution with 0.06 g/ml penicillin and 0.1 g/ml streptomycin at
34–37 ◦C and processed within 3 h of collection. For COCs retrieval
from follicles, ovaries were sliced using a sterile disposable scalpel
blade and collected in wash medium (BO-WASH, IVF Bioscience,
Cornwall, UK). Retrieved COCs were then filtered using a 100 µm
cell strainer (Corning Falcon, Corning, NY, USA). Compact COCs
were chosen based on their morphology, i.e., the presence of at least
two layers of compact cumulus cells and evenly granulated ooplasm.
Selected COCs were then washed four times with wash medium
(BO-WASH, IVF Bioscience, Cornwall, UK) and used immediately
in further experiments.
In vitro embryo production and treatment with
HIF1alpha blockers
In vitro embryo production (IVP) was performed following a stan-
dardized protocol and according to instructions from IVF Bioscience
(Cornwall, UK). Thus, 30 COCs were pooled for each experimental
group in every experiment. Experiments were repeated 3–10 times
with ovaries from different animals in each experiment. The exper-
imental design, presented schematically in Figure 1, included the
following groups: immature COCs, IVM COCs, and IVM COCs
in the presence of an HIF1alpha blocker. Two different classes of
HIF1alpha blockers, with different modes of action, were used:
echinomycin (a blocker of HIF1alpha DNA binding capability),
was used throughout the study; and the PX-478 compound, which
was used in some experiments. The latter decreases HIF1A mRNA
expression and its translation, and inhibits deubiquitinization of
HIF1alpha, cumulatively decreasing its cellular availability [45].
For the immature group, directly after slicing ovaries and select-
ing COCs, cumulus cells were separated from oocytes using 80 IU/ml
hyaluronidase (GM501, Lensahn, DE) for 5 min at 37 ◦C. After
denudation, cumulus cells were pooled by centrifugation (1000 g,
10 min), collected and stored at −80 ◦C until further analysis.
The IVM protocol was applied for 24 h in 0.5 ml maturation
medium (BO-IVM, IVF Bioscience, Cornwall, UK; medium con-
taining gonadotropins with FSH and LH activities) at 38.5 ◦C,
under a 5% CO2 and 20% O2 atmosphere, for both control and
treatment groups. The concentrations of HIF1alpha blockers used
were based on previous studies: 5 nM echinomycin [42, 43], and
25 and 50 µM PX-478 [45]. Following IVM, COCs were denuded
using hyaluronidase as described above, and cumulus cells were
stored at −80 ◦C. Then, oocytes were checked for the extrusion of
the first polar body for the calculation of oocyte maturation rates.
Additionally, the IVM medium (control and echinomycin-treated)
was collected and stored at −80 ◦C for subsequent P4 content
analysis by a competitive radioimmunoassay (RIA), as described
previously [46]. Furthermore, in parallel, for each experiment, in
vitro fertilization (IVF) was performed using all COCs from each
IVM protocol (i.e., control vs. echinomycin- or PX-478-treated),
and blastocyst rates were compared; only expanded and hatched
blastocysts were counted at day 8 of in vitro culture (IVC) (Figure 1).
Briefly, the following IVF protocol was used. The density gra-
dients used for sperm selection were created by the dilution of
BoviPure with BoviDilute (both from Nidacon International AB,
Gothenburg, SE) to concentrations of 80 and 40% (v/v). Equal
volumes of both gradient layers were placed in one Eppendorf tube,
with thawed cryopreserved sperm (0.25 ml) layered on top, and the
preparation centrifuged at 300 g for 15 min. After removing the
supernatant, the pellet was washed with Semen Preparation medium
(IVF Bioscience, Cornwall, UK) and centrifuged twice at 350 g for
3 min. Then, 1 × 106 spermatozoa were added to each fertilization
well with 30 COCs in 500 µl IVF medium (BO-IVF, IVF Bioscience,
Cornwall, UK). Fertilization was performed at 38.5 ◦C under a 5%
CO2 and 20% O2 atmosphere in a humidified incubator (Inkubator
C16, Labotect, Göttingen, DE) for 19 h. For subsequent IVC of








































































482 A. Turhan et al., 2021, Vol. 104, No. 2
UK), covered with 0.4 ml paraffin oil (BO-OIL, IVF Bioscience,
Cornwall, UK), were placed in a humidified incubator (38.5 ◦C, 6–
7% CO2, 6% O2) (Inkubator C16, Labotect) for 8 days. Blastocyst
rates were assessed on day 8 after fertilization.
RNA isolation and semi-quantitative real time
(TaqMan) PCR
The expression of selected target genes from different functional
groups was determined in collected cumulus cells following
IVM (Table 1). Those included: markers of cumulus expansion,
indicators of meiotic resumption and oocyte developmental
competence, steroidogenic markers, glucose transporter, as well
as intercellular communication mediators and PG synthases.
TRIzol reagent (Invitrogen, Carlsbad, CA, USA) was used for
total RNA isolation following the manufacturer’s directions and as
previously described [47]. For elimination of possible genomic DNA
contamination, DNase-treatment was performed with RNase-free
recombinant DNase I (Roche Diagnostics, Basel, CH), following the
manufacturer’s instructions. The RT reaction was performed using
reagents from Applied Biosystems by Thermo Fisher (Waltham,
USA), utilizing random hexamers as primers, according to the
manufacturer’s instructions. cDNA corresponding to 100 ng DNase-
treated total RNA was used for each target gene reaction in semi-
quantitative real time (TaqMan) PCR performed as described
previously [47] in an automated fluorometer ABI PRISM 7500
Sequence Detection System (Applied Biosystems, Thermo Fisher,
Waltham, USA). Custom-made primers and the FAM/TAMRA-
labeled probes were obtained from Microsynth (Balgach, CH),
while commercially available systems were obtained from Thermo
Fisher. Detailed information about TaqMan systems is provided in
Table 1. All samples were analyzed in duplicate, negative controls
were performed either by replacing cDNA with autoclaved water
or with RNA samples that were not reverse transcribed (RT-minus
control). The comparative Ct method (!!Ct method), following
the instructions of the ABI PRISM 7500 fluorometer and as
used previously [47–49], was applied for relative quantification
of target genes expression relative to the expression of two
reference genes (GAPDH and SDHA). Immature COCs were used
as calibrators in each experiment for determining relative gene
expression.
Protein preparation and Western blot
Depending on the availability of the protein material and commercial
antibodies, Western Blot analyses included selected target proteins:
proliferating-cell-nuclear-antigen (PCNA), activated caspase-3
(activated-CASP3), steroidogenic acute regulatory protein (STAR)
and hyaluronan synthase 2 (HAS2), andwas determined in immature
cumulus and compared with in vitro matured cumulus with/without
echinomycin. Following denudation of oocytes, cumulus cells were
collected by centrifugation (1000 g, 10 min), the supernatant was
discarded and the cell pellet resuspended in 10 µl NET-2 lysis buffer
(50 mM Tris-HCl, pH 7.4, 300 mM NaCl, 0.05% NP-40). Proteins
were then sonicated (Vibra-Cell 75186, Weilburg, USA) at 75 W for
10 s and solubilized in sample buffer (25 mM Tris-Cl, pH 6.8, 1%
SDS, 5% b-mercaptoethanol, 10% glycerol, 0.01% bromophenol
blue). Protein concentration was measured by Bradford assay in a
Smart Spec Plus spectrophotometer (Bio-Rad Laboratories, Munich,
DE) and the Western blot assay was performed as previously
described [49]. Proteins (20–30 µg) were loaded onto 12 or 15%
polyacrylamide gel (Bio-Rad), transferred into methanol-activated
polyvinylidene difluoride (PVDF) membranes (Bio-Rad) and probed
with primary antibodies: anti-HIF1alpha (HIF1A, rabbit polyclonal,
Novus Biologicals Europe, Abington, UK, catalog number NB100-
134, diluted 1:1000), anti-STAR (polyclonal rabbit, a gift from Dr
DM Stocco, Texas Tech University Health Sciences Center, Lubbock,
TX, USA [50], diluted 1:5000), anti-PCNA (proliferation marker;
mouse monoclonal, ABCAM, Cambridge, UK, catalog number:
AB29, diluted 1:1000), anti-HAS2 (HA synthase; polyclonal rabbit,
catalog number: LS-C411405/113976, LSBio, Seattle, Washington,
USA, diluted 1:1000), and anti-activated-CASP3 (rabbit monoclonal,
catalog number: 559565, BD Biosciences, Allschwill, CH, diluted
1:200). For loading controls and semi-quantitation of target
protein expression, PVDF membranes were reblotted with mouse
monoclonal antibody against B-Actin (sc-81178) from Santa Cruz
Biotechnology, Inc. (Santa Cruz, CA, USA), diluted 1:1000. The
following secondary antibodies were used: donkey anti-rabbit HRP-
labeled IgG, catalog number: 31460 from Pierce Biotechnology,
Rockford, IL, USA, and HRP conjugated anti-mouse IgG, catalog
number: W402B from Promega, Dübendorf, CH, both used at
dilution 1:30000. Signals were detected with SuperSignalWest
chemiluminescent substrate (Pierce Biotechnology, Rockford, USA)
according to the manufacturer’s protocol and visualized with a
ChemiDoc XRS + System and Image Lab Software, in the presence
of the Precision PlusProtein Standard (molecular weight marker)
ranging from 10 to 250 kDa (all from Bio-Rad). A fine-point
phosphorescent ink marking pen Glow Writer (MIDSCI, St. Louis,
Valley Park, USA) was used to annotate the visible protein ladder
in the ChemiDoc XRS + System. Semi-quantification of protein
expression was performed using ImageJ Software (US National
Institutes of Health, Bethesda, MD, USA). Representative Western
blots are shown (Figures 4 and 5).
Statistical analysis
Statistical analysis was performed by either one-way analysis of
variance (ANOVA) or unpaired, two-tailed Student t-test. In the case
of ANOVA yielding P ≤ 0.05, the analysis was followed by a Tukey–
Kramer multiple comparisons test for pairwise comparisons. For all
tests, P ≤ 0.05 was considered to be statistically significant. Results
are presented as mean and SEM. The statistics software program
GraphPad 3.06 (GraphPad Software, San Diego, CA, USA) was used
for all analyses.
Results
HIF1alpha activity during IVM is needed for cumulus
expansion and expression of selected target genes in
bovine cumulus cells
Following IVM, cumulus expansion was observed in the control
group of COCs, as expected, but it was greatly inhibited in the
echinomycin treated group (Figure 2). At the gene expression level,
transcripts of all targets were clearly detectable, and when compared
with immature COCs, significantly elevated levels of the following
genes were induced during IVM: HAS2, TMSB4 and -10, CX43,
PTGES (P < 0.001 each), TNAIP6 and COX2 (P < 0.01 each),
GATM,GLUT1, and STAR (P< 0.05 each) (Figure 3). Echinomycin
treatment prevented these effects for all these genes (Figure 3), and
apart from HAS2 and GATM, the expression levels were similar to
those of immature COCs (P > 0.05). HAS2 and GATM appeared
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Table 1. List of gene symbols, corresponding gene names, accession numbers and TaqMan systems used for gene expression analysis
Gene Name Accesion number Taqman sytem Product
length
(bp)
HIF1alpha (HIF1A) Hypoxia-inducible factor 1 alpha NM_174339.3 Commercially available:
Applied Biosystems, prod. no. Bt03259341_m1
109
Markers of cumulus expansion (hyaluronic acid metabolism)
HAS Hyaluronan synthase 2 NM_174079.2 Commercially available:
Applied Biosystems, prod. no. Bt03212695_g1.
119




Applied Biosystems, prod. no. Bt03210224_m1
124
Indicators of meiotic resumption
TMSB4 Thymosin beta-4 XM_005222037.4 Forward 5’-GCG CCT CTG CAA CCA TGT-3’
Reverse 5’-CGA AGG CAG TGG ATT TCT CTC T-3’
TaqMan probe 5’-CCC GAT ATG GCT GAG ATT GAG AAG TTC G-3’
107
TMSB10 Thymosin beta-10 AF294616.1 Forward 5’-GGA TTC TCC ACC GCA TCA TCT-3’
Reverse 5’-GGG TTC ACA GTG CAG CTT GTC-’





NM_174189 Forward 5’-AA GTC CCT CAA GGA CCA AAC TC-3’
Reverse 5’-TG CGA GAG GAC CTG GTT GAT-3’




NM_174343 Forward 5’-CAC ACC GCC TCT GTC ATT GA-3’.
Reverse 5’-GTA CGC TGG CCT GGA CAC A-3’
TaqMan probe 5’-TGC TGT CCC GCG AGA CCA TCA-3’
78
Indicators of oocyte developmental competence
GATM Glycine amidinotransferase NM_001045878.1 Commercially available:





Applied Biosystems, prod. no. Bt03212860_g1.
96
Glucose transporter
SLC2A1 (GLUT1) Solute carrier family 2 member
1(glucose transporter 1)
NM_174602.2 Commercially available:
Applied Biosystems, prod. no. Bt03215311_g1
102
Mediator of intercellular communication
GJA1 (CX43) Gap junction alpha-1 protein
(connexin 43)
NM_174068.2 Commercially available:
Applied Biosystems, prod. no. Bt03244351_m1
67
Prostaglandin synthases
PTGS2 (COX2) Prostaglandin 2 synthase
(Cyclooxygenase-2)
NM_174445 Forward 5’-GCA CAA ATC TGA TGT TTG CAT TC-3’
Reverse 5’-GGT CCT CGT TCA AAA TCT GTC T-3’
TaqMan probe 5’-TTG CCC AGC ACT TCA CCC ATC AAT T-3’
76
PTGES Prostaglandin E2 synthase NM_174443 Forward 5’-CAA GTG AGG CTG CGG AAG A-3’
Reverse 5’-AGG CAG CGT TCC ACA TCT G-3’







NM_001012519 Forward 5’-ACC TGG ACC TCT ACC TCA TCC A-3’
Reverse 5’-TCC TCA TCC AAT GGG AAG AAG T-3’





NM_001034034 Forward 5’-GCG ATA CTC ACT CTT CTA CCT TCG A-3’
Reverse 5’-TCG TAC CAG GAA ATG AGC TTG AC-3’





NM_174178 Forward 5’-ATG GAA GGT CTC TGC GCT AT-3’
Reverse 5’-ATG GAC CCG TTC TTC TAT GG-3’
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Figure 2. Representative micrographs showing the morphology of COCs after echinomycin treatment. (A) immature COCs, (B) COCs following control IVM
(IVM/control), (C) COCs treated with echinomycin (5 nM) during IVM (IVM/E).
HIF1alpha yielded lower transcript levels than in immature cumulus
cells (P < 0.05 and P < 0.01, respectively; Figure 3). IVM was asso-
ciated with decreased expression of NPR2, AKR1B1 (20alphaHS-
D/PGFS), as well as ofHSD3B (P< 0.05), regardless of the presence
of echinomycin (Figure 3),with no statistically significant differences
between both IVM groups, i.e., either treated or not with echino-
mycin (P > 0.05).
The expression of target genes was also evaluated in the cumulus
cells of COCs exposed to PX-478. The levels of HIF1A transcript,
which were increased during IVM (P< 0.05), decreased significantly
following exposure to PX-478 (P < 0.01) compared with IVM/-
control, with both dosages of the blocker (25 and 50 µM) being
equally effective. Similar effects were observed at the protein level.
Thus, while HIF1A increased (P < 0.001) in IVM/control group, its
levels were suppressed (P < 0.01) in PX-478-treated cumulus cells,
but not in those cumulus cells derived from echinomycin-treated
COCs (Figure 4). The expression of expansion and maturation-
related target genes was significantly reduced (P < 0.05) in cells
from treated COCs, compared with their levels in IVM/control
cumulus cells (Figure 4), with similar expression patterns to those
observed with echinomycin treatment. The expression of NPR2
was significantly lower than that observed in IVM/control cells in
response to 50 µMPX-478 treatment (P< 0.05).Details of statistical
analyses are presented on Figure 4.
HIF1alpha regulates expression of functional protein
markers in cumulus cells during IVM
The expression of representative markers of steroidogenesis (STAR),
hyaluronan synthase (HAS2), proliferation marker (PCNA), and
proapoptotic activated-CASP3 was assessed byWestern blot analysis
of cumulus cells matured in the presence and absence of echinomycin
(Figure 5). Although clearly detectable and abundantly expressed in
normally matured cumulus cells, STAR, HAS2, and PCNA expres-
sion was significantly suppressed in treated cumulus cells (P < 0.05;
Figure 5). For the STAR expression assessment, the specificity of the
antibody to recognize bovine protein was verified by including a
positive control with proteins from murine immortalized granulosa
KK1 cells cultured as previously described [42]. The expression
of activated-CASP3 was generally low in cumulus cells from both
groups and was not significantly altered in treated cumulus cells
(P = 0.14; Figure 5).
Functional suppression of HIF1alpha during in vitro
maturation reduces steroidogenic output from
cumulus cells and alters IVM/IVP outcome from
treated COCs.
The biological effects of HIF1alpha suppression by echinomycin or
PX-478 were assessed by evaluating oocyte maturation rates (first
polar body extrusion) and blastocyst rates (expanded and hatched
blastocysts) obtained from treated COCs. The oocyte maturation
rates were decreased in echinomycin-treated COCs, compared with
their untreated controls (77 vs. 44%; P < 0.001, Figure 6A), as
were the blastocyst rates, calculated based on matured COCs (IVP
output; 45 vs. 28% P < 0.001, Figure 6A). In addition, P4 output
was significantly lower in treated COCs (Figure 6B; P < 0.05).
Similar functional effects were observed following treatment with
PX-478 (Figure 6C). Thus, the oocyte maturation rates decreased
significantly in COCs treated with 25 µM PX-478 and 50 µM PX-
478 (73 vs. 57 or 45%, respectively; P < 0.05 and P < 0.01).
Blastocyst yields were also significantly lower from COCs exposed
to PX-478 during IVM: 43 vs. 34% (P < 0.01) after 25 µM PX-478
treatment, and 43 vs. 24% (P< 0.01) after 50 µMPX-478 treatment.
Discussion
HIF1alpha is one of the main factors modulating cellular response
to hypoxia. As shown in vitro, it regulates functions of steroidogenic
cells under reduced O2 tension as well as under normoxic conditions
[42, 51]. This, at least in part, appears to be due to its responsive-
ness to different stimuli, constituting the O2-independent regulation
of HIF1alpha availability [52]. Consequently, although apparently
deviating from physiological conditions, cells in vitro appear to cope
with varying O2 levels, still maintaining their HIF1alpha respon-
siveness. Here, using a standardized IVP protocol, we addressed the
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Figure 3. Effects of functional HIF1alpha suppression on target gene expression in cumulus cells derived from COCs as evaluated by semi-quantitative (TaqMan)
real time PCR. Three experimental groups were involved: immature COCs (Immat.), control in vitro matured COCs (IVM/control), and COCs treated with
echinomycin (5 nM) during IVM (IVM/E). The effect of functional HIF1alpha suppression on gene expression of target genes in cumulus cells was tested by
one-way ANOVA, revealing: HAS2 (P < 0.0001), TNFAIP6 (P < 0.0001), TMSB4 (P = 0.0001), TMSB10 (P = 0.005), GATM (P < 0.0001), NPR2 (P = 0.036), GLUT1
(P = 0.0008), CX43 (P = 0.0001), COX2 (P = 0.001), PTGES (P < 0.0001), AKR1B1 (PGFS/20αHSD) (P < 0.0001), STAR (P = 0.0001), and HSD3B (P < 0.0001).
Tukey–Kramer multiple comparisons post-test was applied to test the effect of treatment on gene expression (solid lines). Bars with asterisks differ at: ∗P < 0.05,
∗∗P < 0.01, ∗∗∗P < 0.001, as indicated on the figure. Results are presented as mean ± SEM.
cell function, mirrored in alterations of expression of genes regarded
as markers of oocyte maturation. The ultimate goal was to provide
a functional insight into the underlying molecular and biological
effects of HIF1 complexes and their importance for successful IVM
in cattle. The functional consequences of interference with bio-
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Figure 4. Effects of the suppression of HIF1alpha expression by PX-478 on target gene expression in cumulus cells derived from COCs as evaluated by semi-
quantitative (TaqMan) real time PCR. The following experimental groups were involved: immature COCs (Immat.), control in vitro matured COCs (IVM/control),
and COCs treated with two dosages of PX-478 (25 and 50 µM) during IVM (IVM/25 µM PX-478 and IVM/50 µM PX-478). The one-way ANOVA was applied to
test the effect of HIF1alpha suppression on gene expression in treated cells, revealing: HIF1A (P = 0.0016), HAS2 (P = 0.018), TNFAIP6 (P = 0.0006), TMSB4
(P < 0.0001), TMSB10 (P = 0.0002), GATM (P = 0.002), NPR2 (P < 0.0001), GLUT1 (P = 0.004), CX43 (P = 0.06), COX2 (P = 0.001), PTGES (P = 0.005), AKR1B1
(P = 0.004), STAR (P = 0.002), and HSD3B (P = 0.002). Additionally, the HIF1A protein levels were determined byWestern blot analysis in all experimental groups,
i.e., immature, as well as in control and PX-478 (50 µM) and echinomycin (5 nM) treated IVM groups. The one-way ANOVA was applied revealing P < 0.0001.
Tukey–Kramer multiple comparisons post-test was applied to test the effect of treatment on gene and/or protein expression (solid lines). Bars with asterisks
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Figure 5. Effects of functional HIF1alpha suppression on protein expression of STAR, HAS2, PCNA, and activated-CASP-3 in cumulus cells. Cumulus cells were
collected from COCs matured in vitro in the absence (IVM/control) or presence of echinomycin (5 nM) (IVM/E). Cells were denuded, collected, and homogenized;
25–30 µg of total protein were used for Western blot analysis. Representative Western blots are shown. Student t-test, unpaired, two-tailed, was applied; the
average standardized optical density is shown (mean ± SEM) for: (A) STAR 30 kDa, (B) HAS2, 64 kDa, (C) PCNA 29 kDa, and (D) activated-CASP3, 17kDa. B-
ACTIN was used as loading control (45 kDa). For STAR expression, mouse granulosa KK1 cells were used [42]. Solid lines placed over bars indicate a statistically
significant difference between groups.
by determining oocyte maturation rates (IVM output). Taking it
further, in parallel experiments, oocytes from control COCs and
those treated with HIF1alpha inhibitors were fertilized, allowing the
determination of their functionality in terms of blastocyst output.
By applying a specific blocker of HIF1alpha transcriptional
activity, echinomycin [53], we were able to show an inhibition of
cumulus expansion (Figure 2). We then investigated the expression
of HAS2 and TNFAIP6, selected as markers of cumulus expansion
andmaturation [14], and found their transcript levels were decreased
(Figure 3). Concomitantly, the expression of HAS2 protein was
significantly diminished in cumulus cells from echinomycin-treated
COCs (Figure 5). The decreased expansion of cumulus was also
associated with reduced proliferation of cumulus cells, reflected
in strongly lowered expression of PCNA protein (Figure 5). These
alterations in cell-cycle progression were, however, not related to
the pro-apoptotic activities, as indicated by unaltered, generally
low, levels of activated-CASP3 protein expression (Figure 5). Thus,
despite the cellular level disturbances caused by HIF1alpha with-
drawal, there was no increased apoptosis observed. However, block-
ing of HIF1alpha also affected other mechanisms considered key
for oocyte maturation. For example, the decreased expression of
CX43 suggested negative effects of HIF1alpha blocking on gap
junction functionality. Interestingly, CX43 expression is increased in
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Figure 6. Effects of functional inhibition of HIF1alpha or suppression of its expression, on oocyte maturation rates (IVM output) and steroidogenic output
(progesterone, P4), and on blastocyst rates (IVP output) from bovine COCs treated with HIF1alpha blockers. COCs were treated with either echinomycin (5 nM)
or PX-478 (25 and 50 µM) and the IVM output was determined compared with untreated COCs (IVM/control) (A and C). In parallel experiments, control COCs
and those treated with blockers were further used for IVF, and IVP output was determined by comparing numbers of expanded and hatched blastocysts at day
8 of culture (A and C). The steroidogenic output was determined by RIA in media from control and echinomycin-treated COCs (B). Student t-test, unpaired,
two-tailed, was applied in (A) and (B), and one-way ANOVA was applied in (C), separately for IVM and IVP output (mean ± SEM). Following ANOVA (P < 0.002
and 0.001 for IVM/IVP output, respectively), Tukey–Kramer multiple comparisons post-test was applied to test the effect of the treatment on gene expression
(solid lines). Bars with asterisks differ with: ∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001.
when compared to those with a lower developmental competence,
in vitro [54]. Also, here, CX43 appeared to serve as an indicator
of oocyte quality. Furthermore,GLUT1 downregulation in cumulus
cells from echinomycin-treated COCs suggests a negative effect of
the treatment on glucose transport and therefore on the maintenance
of cellular homeostasis and metabolic capacity and function of
COC elements, i.e., cumulus cells and the oocyte [55]. Based on
these observations, echinomycin-mediated inhibition of HIF1alpha
activity seemed to affect the communication between cumulus cells,
as well as between the corona radiata cells and the oocyte, possibly
affecting its metabolic balance.
Negative effects of functional suppression of HIF1alpha were
also observed with regard to the members of the PGs system, i.e.,
COX2 (PTGS2) and PTGES. An increased production of PGs has
been associated with ovulation in several species [56–58] and the
COX2-derived PGE2 has been shown to be essential for ovulation,
e.g., in mice [59]. Furthermore, besides being involved in ovulation,
PGE2 signaling through its EP2 (PTGER2) receptor is involved in
the limitation of excessive integrin-mediated extracellular matrix
assembly in the cumulus, making it resistant to sperm hyaluronidase
and, thus, preventing sperm penetration [60]. With this, PGE2 con-
tributes also to the successful fertilization of the oocyte. Based on
our findings, both COX2 and PTGES appear to be targets for the
cumulus-expressed HIF1alpha in bovine COCs. Interestingly, this
does not seem to be the case for AKR1B1 (PGFS/20alphaHSD).
Previously known as AKR1B5 [61, 62], the recently renamed bos
taurus AKR1B1 is an aldose reductase, which not only has the
capability to convert PGH2 into PGF2α in a species-specific manner,
but also metabolizes P4 to 20alpha-hydroxyprogesterone [61]. The
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was decreased in matured cumulus cells and was not affected by the
HIF1alpha activity. By decreasing its levels during IVM, AKR1B1
may thus contribute to the maintenance of progesterone availability
in the cumulus. Indeed, steroid production is an important feature of
follicular granulosa cells,with their synthesis via STARmodulated by
HIF1alpha [42, 64], as confirmed in the present study. Although, the
expression of STAR mRNA and protein was significantly increased
during IVM, as expected, it was strongly suppressed in the IVM/E
group of COCs. In our previous findings, neither the expression of
HSD3B protein, nor that of the P450scc (CYP11A1; an enzyme cat-
alyzing the first metabolic step in steroid synthesis, the conversion of
cholesterol to pregnenolone), seemed to be regulated by O2 sensing
in granulosa cells [42]. Accordingly, as shown here, the expression
of HSD3B was not affected by the suppression of HIF1α. With
this, STAR appears to be the HIF1alpha-dependent, rate limiting
candidate gene controlling the steroidogenic output from cumulus
cells during IVM. This is further supported by the significantly
suppressed P4 output measured in medium from treated COCs.
Possible functional consequences of HIF1alpha suppression on
oocyte development were reflected in the suppressed expression of
TMSB4 and TMSB10, used as markers of meiotic resumption [28].
In fact, as shown previously and confirmed here, paralleled by upreg-
ulated levels of COX2, HAS2, as well as of PGR, the expression of
TMSB4 and TMSB10 was increased in a time-dependent manner in
bovine cumulus cells during IVM [28]. It was associated with oocyte
maturation, but not with their competence for fertilization and early
development in vitro [28], as the levels were similar in cumulus from
oocytes that did and did not develop to the blastocyst stage. GATM,
a mitochondrial enzyme involved in arginine metabolism, was previ-
ously associated with blastocyst fate [65]. It was highly expressed
in cumulus from COCs with higher developmental competence
towards blastocyst, and was thus proposed as a biomarker for high-
potential COCs in the cow [65]. In our study, GATM was revealed
to be a highly HIF1alpha sensitive gene; diminishing HIF1alpha
functionality by echinomycin not only prevented its upregulation
during IVM, but similar to HAS2, suppressed its expression levels
to below those seen in immature cumulus cells. Contrasting with
thymosin’s and GATM, the expression of cumulus-derived NPR2
decreased during IVM. Its function is to maintain the oocyte under
meiotic arrest, thereby preventing precocious meiotic resumption
of oocytes in tertiary follicles [66, 67]. Interestingly, the expression
of NPR2 in cumulus appears to be regulated reciprocally by the
oocyte, as its expression decreases when the oocyte is removed, and
it can be restored when the same cumulus cells are incubated with
denuded oocytes [68]. Its decreased expression was thus expected
in our experiments during meiotic resumption. However, although
its expression was apparently decreased, there was no statistically
significant difference between echinomycin-treated vs. non-treated
COCs. Nevertheless, its expression was significantly suppressed
when HIF1alpha expression was diminished by PX-478 (discussed
below).
Having observed the effects of echinomycin on cumulus gene
expression during IVM, and despite knowing its function in block-
ing transcriptional activity of HIF1alpha, it could however still be
considered that echinomycin could interfere with the functionality
of other transcriptional factors, thereby inhibiting the expression of
their target genes. At this point, it is important to mention that in
previous studies similar effects to those obtained with echinomycin
could be achieved upon expression of STAR,CYP19A1 (aromatase),
or VEGF, by applying RNA silencing [42, 43]. Here, in order to
confirm our findings we decided to employ PX-478, a new gener-
ation blocker with alternative modes of action to echinomycin in
targeting and suppressing HIF1alpha expression [45, 69]. Accord-
ingly, contrasting with the functional inhibition of HIF1alpha by
echinomycin not affecting the protein levels of HIF1A, we were able
to confirm the inhibitory effects of PX-478 on HIF1A mRNA and
protein expression in bovine cumulus cells and observed that its
effects in treated COCs were identical and confirmatory with those
observed with echinomycin.
An interesting observation was made with regard to the expres-
sion of NPR2, which was strongly suppressed in treated cumulus,
below the levels observed in two other experimental groups (i.e.
immature and IVM/control). This allowed the conclusion thatNPR2
is also a HIF1alpha responsive gene.With this, as for the other mark-
ers of meiotic resumption, HIF1alpha seems to actively contribute
to the NPR2-mediated control of meiotic arrest in cattle. Functional
studies in support of this conclusion would be of interest.
Finally, the most important functional finding from our study
was that disturbances in the expression of cumulus markers of
COC maturation were followed by significantly decreased oocyte
maturation rates in response to both HIF1alpha blockers, corre-
sponding with the suppressed thymosin’s expression. Furthermore,
as indicated by decreasedGATM expression, in parallel experiments
reduced numbers of expanded and hatched blastocyst were observed
from treated COCs.Consequently, by showing lower blastocyst rates
obtained from treated oocytes, the treatment appeared to affect
developmental competence of oocytes. Our findings demonstrate
that HIF1alpha is functionally involved in controlling IVP output
in cattle, while proposing the underlying mechanism and several
target genes. Whether these effects are directly or indirectly medi-
ated through HIF1alpha needs to be further determined for each
gene. These mechanisms appear to be diverse, involving several
HIF1alpha-mediated pathways, like HA-, TNFAIP6-, and PGE2-
dependent mechanisms controlling cumulus matrix assembly and
cumulus cell proliferation.Other mechanisms involve functional and
metabolic effects characterized by lowered steroidogenic output and
suppression of GLUT1-mediated energy supply. They also affect cell-
to-cell communication and, finally, factors controlling oocyte meiotic
and developmental competence.
Besides highlighting possible pathways and biological mecha-
nisms involved in hypoxia sensing in COCs, our findings emphasize
the importance of HIF1alpha in successful IVP, providing a basis for
further investigations into the underlying mechanisms of hypoxia-
mediated effects during oocyte maturation and, possibly, leading to
further optimization of IVP protocols.
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